Department of Urology, Maastricht University Medical Centre (MUMC+), Mastricht, The Netherlands.
Pelvic Care Centre Maastricht, Maastricht University Medical Centre (MUMC+), Mastricht, The Netherlands.
Urol Int. 2022;106(4):323-343. doi: 10.1159/000513937. Epub 2021 May 31.
Sacral neuromodulation (SNM) is an effective treatment in patients with overactive bladder syndrome or nonobstructive urinary retention when conservative treatment fails. Several factors that could impact outcome with SNM have been studied. This systematic review investigated these predictive factors and their relevance for clinical practice.
Systematic review according to the PRISMA guidelines was conducted. This review is registered in the PROSPERO register (CRD42015016256).
Seventy-eight studies (of which 11 abstracts) were included. Females, younger patients, and a tined lead procedure tend to be predictive in successful SNM outcome. Factors that did not influence SNM outcome were prior back surgery, surgery for stress urinary incontinence, affective symptoms, and duration of complaints. Reduced detrusor contractility is associated with a lower success rate. The level of evidence of most studies (graded according to the Centre for Evidence-Based Medicine) was 3b.
Even though this systematic review investigated predictive factors (gender, age, type of procedure, type of lead, and detrusor contractility), no general consensus on predictive factors could be made. Most studies are small, retrospective, and involve a heterogeneous population. Therefore, prospective research in larger specific patient groups remains necessary to find predictors of SNM outcome.
骶神经调节(SNM)是一种有效的治疗方法,适用于保守治疗失败的膀胱过度活动症或非梗阻性尿潴留患者。已经研究了多种可能影响 SNM 治疗效果的因素。本系统评价调查了这些预测因素及其对临床实践的相关性。
根据 PRISMA 指南进行系统评价。本综述在 PROSPERO 注册中心(CRD42015016256)进行了注册。
共纳入 78 项研究(其中 11 项摘要)。女性、年轻患者和使用带刺电极的手术程序往往是 SNM 治疗成功的预测因素。不会影响 SNM 治疗效果的因素包括既往背部手术、治疗压力性尿失禁的手术、情感症状以及症状持续时间。逼尿肌收缩力降低与较低的成功率相关。根据循证医学中心(Centre for Evidence-Based Medicine)的分级,大多数研究的证据水平为 3b 级。
尽管本系统评价调查了预测因素(性别、年龄、手术类型、电极类型和逼尿肌收缩力),但仍无法就预测因素达成普遍共识。大多数研究规模较小、回顾性且涉及异质性人群。因此,仍需要对更大的特定患者群体进行前瞻性研究,以找到 SNM 治疗效果的预测因素。